Twitter | Pretraživanje | |
Pretraživanje Osvježi
Johnson & Johnson Innovation 15. sij
In step with the rapid transformation of startup business models, seed financing continues to evolve. Join Head Sanjay Mistry today to learn more about key changes that can impact life science innovators in 2020.
Reply Retweet Označi sa "sviđa mi se"
MichelleFredericksen 4. lis
resident Entos announces a new partnership! Their Fusogenix drug delivery platform will be used to develop nex gen therapies for inflammatory & autoimmune diseases
Reply Retweet Označi sa "sviđa mi se"
CONNECT 12. stu
Not all funding is created equal – learn about non-dilutive $ sources and how you might get them at on Dec. 3rd. Register now
Reply Retweet Označi sa "sviđa mi se"
Paul Englert 23. tra
Congratulations to Avidity Biosciences, a alumni, on their $35M research and licensing collaboration for their antibody-oligonucleotide technology! Under the new deal, they could receive additional funds of up to $405M in…
Reply Retweet Označi sa "sviđa mi se"
JLABS 29. sij
It’s almost time! Tomorrow, come meet the team and learn about joining the JLABS @ San Diego community. See you there:
Reply Retweet Označi sa "sviđa mi se"
Janelle Hunt 12. pro
Reply Retweet Označi sa "sviđa mi se"
Taryn 10. lis
📣 Got a speech coming up soon? Get an insider tip from in link below 👇 Don't forget to be there in person for program 10.17 Register:
Reply Retweet Označi sa "sviđa mi se"
JLABS 27. sij
Creating potentially life changing science is hard work – but, you don’t have to do it alone! Get a feel for what it’s like to be part of the community & meet the team 1/29 👉
Reply Retweet Označi sa "sviđa mi se"
Kara Bortone 22. svi
50% chance of showers, 100% chance of funds - resident Locana announces a $55M series A round for their RNA targeting
Reply Retweet Označi sa "sviđa mi se"
Brittney Sabbah 3. pro
Should you hire a grant writer? ✏️ Opinions are mixed - a good strategy is to write the grant yourself (nobody knows the science better!) and have an external advisor do a mock review
Reply Retweet Označi sa "sviđa mi se"
JLABS 4. stu
DYK almost 2x as many women die of lung cancer than breast cancer? * gathers leading researchers & innovators to talk breakthrough innovations 11/14 *source:
Reply Retweet Označi sa "sviđa mi se"
Jeff Calcagno 14. stu
Fall funding news for Avidity Biosciences - $100M raised to advance pioneering science to treat rare muscle disorders Troy Wilson is a terrific founder and now Sarah Boyce as CEO.
Reply Retweet Označi sa "sviđa mi se"
California Life Sciences Association (CLSA) 28. kol
Is your startup advancing science that could prevent biological, chemical or infectious disease threats? Apply to meet with by 9/5:
Reply Retweet Označi sa "sviđa mi se"
Breanne Halyk 1. srp
From a handful companies at the start of in 2012, to 560+ globally today – reflects on the purpose & impact of on the innovation ecosystem in San Diego and beyond
Reply Retweet Označi sa "sviđa mi se"
Hannah 14. stu
Progress towards late stage clinical development for alumni, EpicentRX - $35M series D announced to advance their cancer immunotherapy
Reply Retweet Označi sa "sviđa mi se"
Johnson & Johnson Innovation 15. sij
Sanjay Mistry highlights incubation model is no strings attached, offering mentorship, expertise, & a “community of companies” of shared learning among residents.
Reply Retweet Označi sa "sviđa mi se"
James Viola 24. ruj
Congratulations resident, Phoenix Molecular Designs who received clearance to enter Phase 1/1b clinical trials for PMD-026 an RSK inhibitor targeting advanced ,read more:
Reply Retweet Označi sa "sviđa mi se"
MichelleFredericksen 29. lis
From cutting-edge immunotherapy to disease treatment through genomics - catch groundbreaking science addressing lung cancer at 11/14
Reply Retweet Označi sa "sviđa mi se"
Kara Bortone 23. tra
Shout out to alumni Poseida who raised $142M on Series C round of funding. Congratulations!! Read more:
Reply Retweet Označi sa "sviđa mi se"
Taryn 14 h
Are you weighing the options of debt vs. equity in your startup’s finance strategy? Hear from experts from Correlation Ventures, Avidity Biosciences & SVB 2.27
Reply Retweet Označi sa "sviđa mi se"